A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening

International Journal of Cancer

Volumn 136, Issue 6, 2015, Pages 1411-1421

  Beckmann, Kerri R ^a   Lynch, John W ^a   Hiller, Janet E ^a,b   Farshid, Gelareh ^c   Houssami, Nehmat ^d   Duffy, Stephen W ^e   Roder, David M ^f  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c BreastScreen SA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Breast cancer; Mammography screening; Over diagnosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; POPULATION BASED CASE CONTROL STUDY; RESIDENTIAL AREA; BREAST NEOPLASMS; CASE CONTROL STUDY; EARLY DIAGNOSIS; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED;

EID: 84922255433     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29124     Document Type: Article

References (41)

1. International Agency for Research on Cancer. IARC handbooks of cancer prevention, vol. 7: Breast cancer screening. IARC Press, Lyon, France, 2002.
2. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
3. U.S. Preventive Services Task Force. Screening of breast cancer: recommendations and rationale. Ann Intern Med 2002;137:344-6.
4. Glasziou P, Houssami N. The evidence base for breast cancer screening. Prevent Med 2011;53:100-2.
5. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778-86.
6. Gabe R, Duffy SW. Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 2005;16:153-62.
7. Walter SD. Mammographic screening: case-control studies. Ann Oncol 2003;14:1190-2.
8. Schopper D, de Wolf C. How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009;45:1916-23.
9. Paci E, Duffy S. Overdiagnosis and overtreatment of breast cancer - overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005;7:266-70.
10. Biesheuvel C, Barratt A, Howard K, et al. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129-38.
11. Morrison AS. Screening in Chronic Diseaseed. Oxford: Oxford University Press, 1985.
12. Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012;19(Suppl 1):42-56.
13. de Gelder R. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011;33:111-121.
14. Puliti D, Miccinesi G, Zappa M, et al. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012;14:R9.
15. Puliti D, Zappa M, Miccinesi G, et al. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166-71.
16. Falk RS, Hofvind S, Skaane P, et al. Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer 2013;133:705-12.
17. Njor SH, Olsen AH, Blichert-Toft M, et al. Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ 2013;346:f1064.
18. Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ 2013;185:E492-8.
19. LinkageWiz. Linkage Wiz data matching software, LingageWiz Software, Payneham, Australia, 2002.
20. Centre for Disease Control and Prevention. Registry Plus Link Plus. Atlanta, GA: CDC, 2010.
21. Australian Bureau of Statistics. Information paper: an introduction to socio-economic indexes for areas (SEIFA), 2006. ABS, 2008.
22. Department of Health and Aged Care. Measuring remoteness: accessibility/remoteness index fo Australia (ARIA), revised edn. Department of Health and Aged Care, 2001.
23. Australian Bureau of Statistics. 3101.0 - Australian demographic statisitics, June 2012 Canberra: ABS, 2012.
24. Efron B, Tibshirani RJ. An introduction to boot-straped. Boca Raton: Chapman & Hall, 1993h.
25. Beckmann KR, Roder DM, Hiller JE, Farshid G, Lynch JW. Do breast cancer risk factors differ among those who do and do not undertake mammography screening? J Med Screen 2013.
26. StataCorp. Stata statisitical software: release 12. College Station, TX: StatCorp LP, 2010.
27. Australian Electoral Commission. Size of the electoral roll and estimated participation rate 2010. http://www.aec.gov.au/Enrolling-to-vote/Enrolment-stats/national/2010.htm, 2013. Last accessed 12 March, 2013.
28. Roder D, Houssami N, Farshid G, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008;108:409-16.
29. Pfeiffer RM, Park Y, Kreimer AR, et al. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med 2013;10:e1001492.
30. Zackrisson S, Andersson I, Janzon L, et al. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006;332:689-92.
31. Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30.
32. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230-4.
33. Zahl PH. Overdiagnosis of breast cancer in Denmark. Br J Cancer 2004;90:1686; author reply 7.
34. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. Br Med J 2009;339:b2587.
35. Jorgensen KJ, Zahl PH, Gotzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 2009;9:36.
36. Morrell S, Barratt A, Irwig L, et al. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2010;21:275-82.
37. Zahl PH. Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med 2012;157:220-1; author reply 1-2.
38. Canfell K, Banks E, Clements M, et al. Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003. Breast Cancer Res Treat 2009;117:671-3.
39. Duffy S, Parmar D. Overdiagnosis in breast cancer screening: the importance of length of observation and lead time. Breast Cancer Res 2013;15:R41.
40. Giordano L, von Karsa L, Tomatis M, et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen 2012;19(Suppl 1):72-82.
41. Iared W, Shigueoka DC, Torloni MR, et al. Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis. Sao Paulo Med J 2011;129:250-60.